Abstract / truncated to 115 words (read the full abstract)

Alzheimer’s disease (AD) is a neurodegenerative terminal disorder that accounts for nearly 70% of dementia cases worldwide. Global dementia incidence is projected to 75 million cases by 2030, with the majority of the affected individuals coming from low- and medium- income countries. Although there is no cure for AD, early diagnosis can improve the quality of life of AD patients and their caregivers. Currently, AD diagnosis is carried out using mental status examinations, expensive neuroimaging scans, and invasive laboratory tests, all of which render the diagnosis time-consuming and costly. Notwithstanding, over the last decade electroencephalography (EEG), specifically resting-state EEG (rsEEG), has emerged as an alternative technique for AD diagnosis with accuracies inline with those obtained ... toggle 6 keywords

alzheimer’s disease – electroencephalography – resting-state – amplitude modulation – automated artifact handing – portable eeg

Follow @eurasip